Itaconate enhances oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Naziia Kurmasheva, Aida Said, Boaz Wong, Alena Kress, Zhenlong Liu, Chen Wang, Madalina E. Carter-Timofte, Emilia Holm, Demi van der Horst, Huy‐Dung Hoang, Krishna Sundar Twayana, Rasmus N. Ottosen, Esben B. Svenningsen, Fabio Begnini, Ander Kiib, Hauke J. Weiss, Daniele Di Carlo, Michela Muscolini, Maureen Higgins, Priscilla Kinderman, Mirte van der Heijden, Tong Tong, Attila Ozsvár, Wen‐Hsien Hou, Vivien R. Schack, Christian K. Holm, Nadine van Montfoort, Yunan Zheng, Melanie C. Ruzek, Joanna Kalucka, Laureano de la Vega, Walid A. M. Elgaher, Anders Rosendal Korshoej, Rongtuan Lin, John Hiscott, Thomas B. Poulsen, Luke O'neill, Jean‐Simon Diallo, Henner F. Farin, Tommy Alain, David Olagnier (2023). Itaconate enhances oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways. Research Square (Research Square), DOI: 10.21203/rs.3.rs-3035315/v1.
